Drugs / Seqirus QIV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02545543 | Sep 2015 → Jan 2016 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Seqirus QIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02545543 ↗ |
| Modality | Vaccine | “Seqirus QIV, inactivated, split-virion, thimerosal-free, quadrivalent influenza vaccine” NCT02545543 ↗ |